Acrivon Therapeutics Inc (ACRV) PT Lowered to $14 at Ladenburg Thalmann
Tweet Send to a Friend
Ladenburg Thalmann analyst Aydin Huseynov lowered the price target on Acrivon Therapeutics Inc (NASDAQ: ACRV) to $14.00 (from $18.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
